1
Michael A Horning, George A Brooks: Systems and methods to estimate nutritional needs of human and other patients. RUN THEM SWEET, Robert H Lee, November 7, 2017: US09808031 (3 worldwide citation)

Systems, techniques and methods for estimating the metabolic state or flux, e.g., the body energy state (“BES”) of a patient, are disclosed. The BES provides deep insight into the nutritional needs of the patient, thus allowing for a sort of exquisite glycemic control with regard to the patient. The ...


2
SEXTON FREDERICK A, KRISHNAN SITARAMAN, VENDRA VENKAT KALYAN: LIBERATION PROLONGEE DE NUTRIMENTS IN VIVO, SUSTAINED RELEASE OF NUTRIENTS IN VIVO. NEW WORLD PHARMACEUTICALS, NEW WORLD PHARMACEUTICALS, RIDOUT & MAYBEE, May 23, 2017: CA2747659 (2 worldwide citation)

Nutritional compositions delivered in vivo in a time controlled manner sustainable over long periods of time, pro-vide enhancing athletic performance, increased hand/eye coordina-tion and concentration on the task at hand.


3
Carlo Terruzzi, Fabio Terruzzi: Composition comprising alpha-lipoic acid and honokiol for treating neuropathies. GIELLEPI S P A, Lucas & Mercanti, May 9, 2017: US09642834 (1 worldwide citation)

The present invention relates to a composition comprising alfa-lipoic acid, or a salt or complex thereof, and honokiol, wherein the weight quantity of said honokiol is between 1% and 30% with respect to the total weight of honokiol and alfa-lipoic acid.


4
Jorge Luis Rosado Loria, Miguel Angel Duarte Vázquez: Nutritional composition for children with reflux, colic and/or constipation. Nucitec de C V, Sterne Kessler Goldstein & Fox P L L C, March 14, 2017: US09591872 (1 worldwide citation)

The present invention is directed to an infant formula specially designed to reduce episodes of regurgitation, colic and constipation that occur in infants fed on infant formula. The composition represents a needed improvement to the art because it contains in a single composition substances that si ...


5
USE OF ENZYME-MODIFIED ISOQUERCITRIN. SAN EI GEN F F I, December 6, 2018: US20180344633-A1

The present invention provides a salivator that is in a form for use in the mouth (a form for intraoral use), or in a form for use by oral administration (a form for oral administration). The salivator can be prepared by using enzymatically modified isoquercitrin, or a combination of enzyme-modified ...


6
TURMERIC HEALTH ADDITIVES AND METHODS FOR MAKING SAME. November 29, 2018: US20180339009-A1

Described herein is a method of making an edible turmeric additive comprising the step of cooking a mixture of turmeric and pepper in a neutral oil.


7
Tae Sun Park: Composition including ionone or salt thereof as active ingredient and having effect of enhancing skin moisturizing, exfoliating skin, improving skin elasticity, inhibiting erythema, improving skin wrinkles, or alleviating skin photoaging. YONSEI UNIVERSITY TECHNOLOGY HOLDINGS, Norton Rose Fulbright US, November 27, 2018: US10137070

Provided herein are a cosmetic composition, a health functional food composition, a pharmaceutical composition, and a quasi-drug composition that include ionone or a salt thereof as an active ingredient and have an effect of enhancing skin moisturizing, exfoliating skin, improving skin elasticity, i ...


8
Johannes Bernard Van Goudoever, Eline Marleen Van Der Beek, Marieke Abrahamse Berkeveld, Günther Boehm: Low protein infant formula with increased essential amino acids. N V Nutricia, Gilberto M Villacorta, Sunit Talapatra, Foley & Lardner, November 27, 2018: US10136668

The present invention concerns an improved balance of the essential branched chain amino acids leucine, isoleucine and valine in infant formula.


9
Takahiro Hiramura, Kiyoshi Ikura, Tomohito Okabayashi, Yoshihisa Takigawa, Naohiro Hashikawa: Disintegrative particle composition including pulverized lactose or granulated lactose. DAICEL CORPORATION, Ping Wang, Morris Manning & Martin, November 20, 2018: US10130584

The purpose of the present invention is to provide a new disintegrative particulate composition having an optimal balance between the tablet hardness and disintegrability that are mutually opposing properties, and disintegrating tablets for pharmaceuticals and various kinds of foods comprising said ...


10
Joshua Rabinowitz, Jurre Kamphorst, Craig Thompson, Justin Cross: Lipid scavenging in Ras cancers. Memorial Sloan Kettering Cancer Center, The Trustees of Princeton University, Choate Hall & Stewart, Brenda Herschbach Jarrell, Robert N Sahr, November 20, 2018: US10130600

Methods and compositions for treating Ras-related cancers are provided that involve targeting lipid scavenging. Methods and compositions for identifying and/or characterizing more or less responsive cancers are also provided.